We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Freshworks
FRSH
$3.51B
| $702K | ﹤0.01% |
43,400
| – | – |
|
1152
BOK Financial
BOKF
$8.85B
| $700K | ﹤0.01% |
6,572
+700
| +12% | +$78.1K |
|
|
LTC
1153
LTC Properties
LTC
$2.1B
| $695K | ﹤0.01% |
20,130
+4,000
| +25% | +$148K |
|
1154
Copa Holdings
CPA
$6.17B
| $694K | ﹤0.01% |
7,900
-100
| -1% | -$9.48K |
|
1155
Energizer
ENR
$1.55B
| $694K | ﹤0.01% |
19,888
| – | – |
|
1156
Agilysys
AGYS
$3.25B
| $693K | ﹤0.01% |
5,259
| – | – |
|
1157
Graham Holdings Company
GHC
$4.97B
| $691K | ﹤0.01% |
793
| – | – |
|
1158
Supernus Pharmaceuticals
SUPN
$2.74B
| $691K | ﹤0.01% |
19,116
+1,900
| +11% | +$66.9K |
|
1159
Klaviyo
KVYO
$5.47B
| $689K | ﹤0.01% |
+16,700
| New | +$638K |
|
1160
McGrath RentCorp
MGRC
$2.94B
| $689K | ﹤0.01% |
6,158
| – | – |
|
1161
Zeta Global
ZETA
$7.44B
| $689K | ﹤0.01% |
38,300
-900
| -2% | -$22.7K |
|
|
JWN
1162
DELISTED
Nordstrom
JWN
| $687K | ﹤0.01% |
28,430
+6,600
| +30% | +$152K |
|
1163
HUB Group
HUBG
$2.55B
| $686K | ﹤0.01% |
15,388
| – | – |
|
1164
Cal-Maine
CALM
$3.87B
| $683K | ﹤0.01% |
6,637
+800
| +14% | +$75.5K |
|
1165
Beam Therapeutics
BEAM
$2.74B
| $682K | ﹤0.01% |
27,500
-1,000
| -4% | -$25.5K |
|
1166
Yelp
YELP
$1.32B
| $680K | ﹤0.01% |
17,581
| – | – |
|
1167
Protagonist Therapeutics
PTGX
$9.8B
| $679K | ﹤0.01% |
+17,600
| New | +$767K |
|
1168
CVB Financial
CVBF
$4.08B
| $677K | ﹤0.01% |
31,611
+4,700
| +17% | +$99.4K |
|
|
HI
1169
DELISTED
Hillenbrand
HI
| $677K | ﹤0.01% |
21,997
+5,700
| +35% | +$172K |
|
1170
Braze
BRZE
$3.36B
| $674K | ﹤0.01% |
16,100
+6,800
| +73% | +$247K |
|
1171
Calix
CALX
$2.51B
| $673K | ﹤0.01% |
19,300
| – | – |
|
1172
Viavi Solutions
VIAV
$10.6B
| $673K | ﹤0.01% |
66,610
+7,700
| +13% | +$76K |
|
1173
LGI Homes
LGIH
$1.37B
| $667K | ﹤0.01% |
7,465
+1,100
| +17% | +$115K |
|
1174
Vertex
VERX
$2.15B
| $667K | ﹤0.01% |
12,500
+800
| +7% | +$38.8K |
|
1175
Kymera Therapeutics
KYMR
$9.51B
| $664K | ﹤0.01% |
16,500
-800
| -5% | -$36.1K |
|
Similar funds
GAM
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.